Fibroblast growth factor-2 stimulates interleukin-6 secretion in human pancreatic periacinar myofibroblasts

Akira Andoh, Shigeki Bamba, Sanae Fujino, Osamu Inatomi, Zhuobin Zhang, Shokei Kim, Atsushi Takayanagi, Nobuyoshi Shimizu, Yoshihide Fujiyama

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objectives: Fibroblast growth factor-2 (FGF-2) plays an important role in the pathophysiology of acute and chronic pancreatitis. In the present study, to evaluate the proinflammatory nature of FGF-2, we investigated the effects of FGF-2 on IL-6 secretion in human pancreatic periacinar myofibroblasts. Methods: IL-6 supernatant levels were determined by enzyme-linked immunosorbent assays (ELISA). IL-6 mRNA expression were determined by Northern blots and quantitative PCRs. Activated protein (AP)-1 DNA-binding activities were evaluated by electrophoretic gel mobility shift assays (EMSA). Results: FGF-2 induced IL-6 release in a dose- and time-dependent manner. FGF-2 activity for IL-6 induction was the same as that of IL-17. The combination of FGF-2 and IL-17 exerted additive effects at mRNA and protein levels. FGF-2 induced AP-1 DNA-binding activity, but blockage of AP-1 signaling by adenovirus-mediated transfer of a dominant negative c-Jun gene did not affect FGF-2-induced IL-6 mRNA expression. FGF-2 rapidly induced activation of ERK1/2 and p38 MAP kinases, and specific inhibitors for these enzymes significantly reduced FGF-2-induced IL-6 release. Conclusion: In the pancreas, FGF-2 may not only play a role as a growth factor in tissue injury repair processes but also as an inducer of acute-phase response via stimulation of IL-6 release.

Original languageEnglish
Pages (from-to)278-283
Number of pages6
JournalPancreas
Volume29
Issue number4
DOIs
Publication statusPublished - 2004 Nov

Fingerprint

Myofibroblasts
Fibroblast Growth Factor 2
Interleukin-6
Interleukin-17
DNA-Binding Proteins
Messenger RNA
jun Genes
Acute-Phase Reaction
Chronic Pancreatitis
Electrophoretic Mobility Shift Assay
Enzyme Inhibitors
p38 Mitogen-Activated Protein Kinases
Adenoviridae
Northern Blotting
Pancreas
Intercellular Signaling Peptides and Proteins
Proteins
Gels
Enzyme-Linked Immunosorbent Assay

Keywords

  • Activated protein 1
  • Inflammation
  • Mitogen-activated protein kinase
  • Nuclear factor κB

ASJC Scopus subject areas

  • Gastroenterology
  • Endocrinology

Cite this

Andoh, A., Bamba, S., Fujino, S., Inatomi, O., Zhang, Z., Kim, S., ... Fujiyama, Y. (2004). Fibroblast growth factor-2 stimulates interleukin-6 secretion in human pancreatic periacinar myofibroblasts. Pancreas, 29(4), 278-283. https://doi.org/10.1097/00006676-200411000-00006

Fibroblast growth factor-2 stimulates interleukin-6 secretion in human pancreatic periacinar myofibroblasts. / Andoh, Akira; Bamba, Shigeki; Fujino, Sanae; Inatomi, Osamu; Zhang, Zhuobin; Kim, Shokei; Takayanagi, Atsushi; Shimizu, Nobuyoshi; Fujiyama, Yoshihide.

In: Pancreas, Vol. 29, No. 4, 11.2004, p. 278-283.

Research output: Contribution to journalArticle

Andoh, A, Bamba, S, Fujino, S, Inatomi, O, Zhang, Z, Kim, S, Takayanagi, A, Shimizu, N & Fujiyama, Y 2004, 'Fibroblast growth factor-2 stimulates interleukin-6 secretion in human pancreatic periacinar myofibroblasts', Pancreas, vol. 29, no. 4, pp. 278-283. https://doi.org/10.1097/00006676-200411000-00006
Andoh, Akira ; Bamba, Shigeki ; Fujino, Sanae ; Inatomi, Osamu ; Zhang, Zhuobin ; Kim, Shokei ; Takayanagi, Atsushi ; Shimizu, Nobuyoshi ; Fujiyama, Yoshihide. / Fibroblast growth factor-2 stimulates interleukin-6 secretion in human pancreatic periacinar myofibroblasts. In: Pancreas. 2004 ; Vol. 29, No. 4. pp. 278-283.
@article{3f69197ca7b34ba6b5036bbd4cb15277,
title = "Fibroblast growth factor-2 stimulates interleukin-6 secretion in human pancreatic periacinar myofibroblasts",
abstract = "Objectives: Fibroblast growth factor-2 (FGF-2) plays an important role in the pathophysiology of acute and chronic pancreatitis. In the present study, to evaluate the proinflammatory nature of FGF-2, we investigated the effects of FGF-2 on IL-6 secretion in human pancreatic periacinar myofibroblasts. Methods: IL-6 supernatant levels were determined by enzyme-linked immunosorbent assays (ELISA). IL-6 mRNA expression were determined by Northern blots and quantitative PCRs. Activated protein (AP)-1 DNA-binding activities were evaluated by electrophoretic gel mobility shift assays (EMSA). Results: FGF-2 induced IL-6 release in a dose- and time-dependent manner. FGF-2 activity for IL-6 induction was the same as that of IL-17. The combination of FGF-2 and IL-17 exerted additive effects at mRNA and protein levels. FGF-2 induced AP-1 DNA-binding activity, but blockage of AP-1 signaling by adenovirus-mediated transfer of a dominant negative c-Jun gene did not affect FGF-2-induced IL-6 mRNA expression. FGF-2 rapidly induced activation of ERK1/2 and p38 MAP kinases, and specific inhibitors for these enzymes significantly reduced FGF-2-induced IL-6 release. Conclusion: In the pancreas, FGF-2 may not only play a role as a growth factor in tissue injury repair processes but also as an inducer of acute-phase response via stimulation of IL-6 release.",
keywords = "Activated protein 1, Inflammation, Mitogen-activated protein kinase, Nuclear factor κB",
author = "Akira Andoh and Shigeki Bamba and Sanae Fujino and Osamu Inatomi and Zhuobin Zhang and Shokei Kim and Atsushi Takayanagi and Nobuyoshi Shimizu and Yoshihide Fujiyama",
year = "2004",
month = "11",
doi = "10.1097/00006676-200411000-00006",
language = "English",
volume = "29",
pages = "278--283",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Fibroblast growth factor-2 stimulates interleukin-6 secretion in human pancreatic periacinar myofibroblasts

AU - Andoh, Akira

AU - Bamba, Shigeki

AU - Fujino, Sanae

AU - Inatomi, Osamu

AU - Zhang, Zhuobin

AU - Kim, Shokei

AU - Takayanagi, Atsushi

AU - Shimizu, Nobuyoshi

AU - Fujiyama, Yoshihide

PY - 2004/11

Y1 - 2004/11

N2 - Objectives: Fibroblast growth factor-2 (FGF-2) plays an important role in the pathophysiology of acute and chronic pancreatitis. In the present study, to evaluate the proinflammatory nature of FGF-2, we investigated the effects of FGF-2 on IL-6 secretion in human pancreatic periacinar myofibroblasts. Methods: IL-6 supernatant levels were determined by enzyme-linked immunosorbent assays (ELISA). IL-6 mRNA expression were determined by Northern blots and quantitative PCRs. Activated protein (AP)-1 DNA-binding activities were evaluated by electrophoretic gel mobility shift assays (EMSA). Results: FGF-2 induced IL-6 release in a dose- and time-dependent manner. FGF-2 activity for IL-6 induction was the same as that of IL-17. The combination of FGF-2 and IL-17 exerted additive effects at mRNA and protein levels. FGF-2 induced AP-1 DNA-binding activity, but blockage of AP-1 signaling by adenovirus-mediated transfer of a dominant negative c-Jun gene did not affect FGF-2-induced IL-6 mRNA expression. FGF-2 rapidly induced activation of ERK1/2 and p38 MAP kinases, and specific inhibitors for these enzymes significantly reduced FGF-2-induced IL-6 release. Conclusion: In the pancreas, FGF-2 may not only play a role as a growth factor in tissue injury repair processes but also as an inducer of acute-phase response via stimulation of IL-6 release.

AB - Objectives: Fibroblast growth factor-2 (FGF-2) plays an important role in the pathophysiology of acute and chronic pancreatitis. In the present study, to evaluate the proinflammatory nature of FGF-2, we investigated the effects of FGF-2 on IL-6 secretion in human pancreatic periacinar myofibroblasts. Methods: IL-6 supernatant levels were determined by enzyme-linked immunosorbent assays (ELISA). IL-6 mRNA expression were determined by Northern blots and quantitative PCRs. Activated protein (AP)-1 DNA-binding activities were evaluated by electrophoretic gel mobility shift assays (EMSA). Results: FGF-2 induced IL-6 release in a dose- and time-dependent manner. FGF-2 activity for IL-6 induction was the same as that of IL-17. The combination of FGF-2 and IL-17 exerted additive effects at mRNA and protein levels. FGF-2 induced AP-1 DNA-binding activity, but blockage of AP-1 signaling by adenovirus-mediated transfer of a dominant negative c-Jun gene did not affect FGF-2-induced IL-6 mRNA expression. FGF-2 rapidly induced activation of ERK1/2 and p38 MAP kinases, and specific inhibitors for these enzymes significantly reduced FGF-2-induced IL-6 release. Conclusion: In the pancreas, FGF-2 may not only play a role as a growth factor in tissue injury repair processes but also as an inducer of acute-phase response via stimulation of IL-6 release.

KW - Activated protein 1

KW - Inflammation

KW - Mitogen-activated protein kinase

KW - Nuclear factor κB

UR - http://www.scopus.com/inward/record.url?scp=13644255297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13644255297&partnerID=8YFLogxK

U2 - 10.1097/00006676-200411000-00006

DO - 10.1097/00006676-200411000-00006

M3 - Article

C2 - 15502643

AN - SCOPUS:13644255297

VL - 29

SP - 278

EP - 283

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 4

ER -